rood blauwe elepsis logo Belegger.nl

Galapagos februari 2018

4.984 Posts
Pagina: «« 1 ... 178 179 180 181 182 ... 250 »» | Laatste | Omlaag ↓
  1. forum rang 10 voda 22 februari 2018 21:45
    quote:

    Sir Chanticleer schreef op 22 februari 2018 21:42:

    ik begin vast, wil ook wel eens de eerste zijn.
    Dat gaat je niet lukken. :-)
  2. [verwijderd] 22 februari 2018 21:50
    quote:

    moneymaker_BX schreef op 22 februari 2018 21:46:

    Zijn er bij de analisten helemaal geen verwachtingen want nu kunnen we nooit zeggen het is beter of slechter dan verwacht
    Oh, wat erg! Wat vreselijk!
  3. Al Kipone 22 februari 2018 21:51
    Bank of Montreal Can increased its position in Galapagos NV (NASDAQ:GLPG) by 84.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,205 shares of the biotechnology company’s stock after buying an additional 2,377 shares during the period. Bank of Montreal Can’s holdings in Galapagos were worth $488,000 at the end of the most recent quarter.

    Several other large investors have also recently bought and sold shares of the stock. Orbimed Advisors LLC lifted its position in shares of Galapagos by 84.8% in the third quarter. Orbimed Advisors LLC now owns 523,790 shares of the biotechnology company’s stock worth $53,296,000 after buying an additional 240,290 shares in the last quarter. Alps Advisors Inc. increased its stake in Galapagos by 9.1% during the third quarter. Alps Advisors Inc. now owns 50,045 shares of the biotechnology company’s stock worth $5,092,000 after acquiring an additional 4,177 shares during the last quarter. Dorsey Wright & Associates increased its stake in Galapagos by 44.1% during the third quarter. Dorsey Wright & Associates now owns 48,357 shares of the biotechnology company’s stock worth $4,944,000 after acquiring an additional 14,788 shares during the last quarter. Bank of New York Mellon Corp increased its stake in Galapagos by 7.1% during the third quarter. Bank of New York Mellon Corp now owns 40,813 shares of the biotechnology company’s stock worth $4,152,000 after acquiring an additional 2,720 shares during the last quarter. Finally, JPMorgan Chase & Co. bought a new stake in Galapagos during the third quarter worth approximately $3,072,000. Institutional investors own 19.49% of the company’s stock.
  4. Al Kipone 22 februari 2018 21:55
    :-) (I have a cunning plan: ze lezen het in het nederlands, denken dan dit is heels geen nederlands, pakken Wolters Duits/Nederlands woordenboek erbij, en voor je het weet is het half elf lokale tijd.
  5. Al Kipone 22 februari 2018 21:57
    effe ommetje, muizenissen uit m'n hoofd, lekker fris klaar voor de snelle klik over een uurtje! Tot dan!!
  6. forum rang 10 voda 22 februari 2018 22:00
    200 MB internet connection : status: standby for 98%
    Email addres: open to receive
    IEX adress: open
    Other adress: open

    Other items: Girlfriend locked up in the bedroom, cat on the balcony

    Fully ready for countdown: :^___^:-)
  7. Al Kipone 22 februari 2018 22:01
    Galapagos delivered in 2017
    22 February 2018 at 22:01 CET
    Key 2017 results:

    Expansion of filgotinib franchise:
    Start of 8 new disease area trials
    Opt-in to co-promote in Europe
    Second and third platform successes:
    Halt of disease progression in FLORA trial with GLPG1690 in IPF patients
    Promising results with MOR106 in atopic dermatitis patient trial
    ALBATROSS and FLAMINGO trials with GLPG2222 showed expected activity in cystic fibrosis patients
    Strong biomarker reduction and favorable tolerability with GLPG1972 in osteoarthritis patients
    Group revenues increased by €4.3 million to €155.9 million
    Operating loss increased by €78.3 million to €89.8 million
    Net loss of €115.7 million, compared to a net profit of €54.0 million in 2016
    Operational cash burn of €154.1 million
    Net proceeds from capital increase of €353.4 million
    Cash balance increased by €171.5 million to €1,152.4 million at year-end
4.984 Posts
Pagina: «« 1 ... 178 179 180 181 182 ... 250 »» | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Belegger.nl

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.016
AB InBev 2 5.495
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 51.606
ABO-Group 1 22
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 264
Accsys Technologies 23 10.611
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 188
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.746
Aedifica 3 903
Aegon 3.258 322.696
AFC Ajax 538 7.088
Affimed NV 2 6.296
ageas 5.844 109.889
Agfa-Gevaert 14 2.049
Ahold 3.538 74.331
Air France - KLM 1.025 35.031
AIRBUS 1 11
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.036
Alfen 16 24.766
Allfunds Group 4 1.470
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 406
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.822
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.836 242.995
AMG 971 133.248
AMS 3 73
Amsterdam Commodities 305 6.689
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 491
Antonov 22.632 153.605
Aperam 92 14.992
Apollo Alternative Assets 1 17
Apple 5 381
Arcadis 252 8.772
Arcelor Mittal 2.033 320.682
Archos 1 1
Arcona Property Fund 1 286
arGEN-X 17 10.297
Aroundtown SA 1 219
Arrowhead Research 5 9.731
Ascencio 1 26
ASIT biotech 2 697
ASMI 4.108 39.093
ASML 1.766 106.749
ASR Nederland 21 4.458
ATAI Life Sciences 1 7
Atenor Group 1 485
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 13.661
Axsome Therapeutics 1 177
Azelis Group 1 64
Azerion 7 3.392